SCHEMBL10065909

SCHEMBL10065909

CCCCCCCC/C=C\CCCCCCCCN(CCCCN(CCCCCCCC/C=C\CCCCCCCC)CCCNC(=N)N)CCCNC(=N)N

nearest known ligand 0.47

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 9/20 0.45
MEN1 O00255 1/20 0.44
FAAH O00519 1/20 0.44
TP53 P04637 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C19 P33261 1/20 0.44
SOAT1 P35610 1/20 0.44
KMT2A Q03164 1/20 0.44
SLC6A5 Q9Y345 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12458467 1.00 EPHX2 (0.45) EPHX2MEN1FAAHTP53CYP1A2
SCHEMBL14597533 0.98 EPHX2 (0.44) EPHX2MEN1FAAHTP53CYP1A2
SCHEMBL14597549 0.94 EPHX2 (0.41) EPHX2MEN1FAAHTP53CYP1A2
SCHEMBL10065904 0.91 EPHX2 (0.44) EPHX2MEN1FAAHTP53CYP1A2
SCHEMBL13679062 0.91 EPHX2 (0.44) EPHX2MEN1FAAHTP53CYP1A2
SCHEMBL11321528 0.91 MEN1 (0.42) MEN1CYP1A2KMT2A
SCHEMBL11313633 0.91 MEN1 (0.42) MEN1CYP1A2KMT2A
Hydrochloric Acid SCHEMBL5533556 0.89 SPHK1 (0.43) MEN1CYP1A2KMT2A
SCHEMBL14597551 0.88 EPHX2 (0.42) EPHX2SLC6A5
SCHEMBL10007258 0.87 SLC6A5 (0.54) EPHX2MEN1FAAHTP53CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8158827-B2 Transfection reagents Life Technologies Corporation (US) 2012-04-17 US disclosed
US-7915450-B2 Transfection reagents Life Technologies Corporation (US) 2011-03-29 US disclosed
US-20100159593-A1 TRANSFECTION REAGENTS Life Technologies Corporation (US) 2010-06-24 US disclosed
US-20090143583-A1 TRANSFECTION REAGENTS Life Technologies Corporation (US) 2009-06-04 US disclosed
US-7470817-B2 Transfection reagents INVITROGEN CORPORATION (US) 2008-12-30 US disclosed
US-7323594-B2 Transfection reagents INVITROGEN CORPORATION (US) 2008-01-29 US disclosed
US-20070202598-A1 NEW TRANSFECTION REAGENTS INVITROGEN CORPORATION (US) 2007-08-30 US disclosed
US-20070202600-A1 TRANSFECTION REAGENTS INVITROGEN CORPORATION (US) 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070202598-A1 NEW TRANSFECTION REAGENTS PHAX, CPS1, HNRNPH3 EPHX2 2943/4885MEN1 3272/4885FAAH 4765/4885
US-20090143583-A1 TRANSFECTION REAGENTS CPS1, PHAX, HNRNPH3 EPHX2 3352/4885MEN1 2692/4885FAAH 4762/4885
US-20100159593-A1 TRANSFECTION REAGENTS CPS1, PHAX, HNRNPH3 EPHX2 3358/4885MEN1 2613/4885FAAH 4763/4885
US-20070202600-A1 TRANSFECTION REAGENTS CPS1, PHAX, HNRNPH3 EPHX2 3469/4885MEN1 2426/4885FAAH 4767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.